Inland Peptides
Inland Peptides

KPV

Research Snapshot Last reviewed October 2026
No

Approved by the FDA for human use

No

Studied in human clinical trials

No

Published human research

Yes

Published animal research

Primary research areas
  • Intestinal inflammation

View in catalog →

Overview

KPV is a peptide made of three amino acids: lysine, proline, and valine. It is a fragment of alpha-melanocyte-stimulating hormone, studied mainly for inflammation.

KPV is not approved by the Food and Drug Administration for human use, and no prescription version exists. It should only be used within an approved clinical study and never taken without a doctor’s authorization.

What is it being studied for?

Research is focused on inflammation in the gut, particularly colitis. It has also been studied for skin inflammation.

Intestinal cells can absorb KPV through a transporter for small peptides. Laboratory studies suggest it reduces signals involved in inflammation.

What has research found?

In mouse studies, KPV reduced intestinal inflammation. Another study tested oral KPV enclosed in tiny particles to deliver it to the colon in mice with colitis.

Human treatment studies have not established KPV’s benefits or side effects.

FDA status and development history

KPV has been studied in academic laboratories for inflammation. It is not FDA-approved for human use.